Sulfonylureas

Journal articles and book chapters

05-18-2018 | Type 2 diabetes | Review | Article

Combination glucose-lowering therapy plans in T2DM: Case-based considerations

Blonde L, Dipp S, Cadena D. Adv Ther 2018. doi: 10.1007/s12325-018-0694-0

05-18-2018 | Gestational diabetes | Review | Article

Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes

Yeung RO et al. Rev Endocr Metab Disord 2018. doi: 10.1007/s11154-018-9446-3

05-09-2018 | Liraglutide (T2DM) | Article

Real-world clinical effectiveness and cost savings of liraglutide versus sitagliptin in treating type 2 diabetes for 1 and 2 years

Li Q et al. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0432-2

05-08-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: Do oral agents have a place?

Corcoy R et al. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.015

05-04-2018 | GLP-1 agonists | Review | Article

Glucagon-like peptide 1 in health and disease

Andersen A et al. Nat Rev Endocrinol 2018; Advance online publication. doi: 10.1038/s41574-018-0016-2

05-01-2018 | Glyburide | Article

Effect of glyburide vs subcutaneous insulin on perinatal complications among women with gestational diabetes: A randomized clinical trial

Sénat MV et al. JAMA 2018; 319: 1773–1780. doi: 10.1001/jama.2018.4072

04-10-2018 | Sulfonylureas | Article

Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: Analyses from the EASYDia trial

Leiter LA, Shestakova MV, Satman I. Diabetol Metab Syndr 2018; 10: 30. doi: 10.1186/s13098-018-0331-8

02-15-2018 | MODY | Review | Article

Clinical management of women with monogenic diabetes during pregnancy

Dickens LT, Naylor RN. Curr Diab Rep 2018; 18: 12. doi: 10.1007/s11892-018-0982-8

02-06-2018 | Post-transplant diabetes mellitus | Review | Article

Post-liver transplantation diabetes mellitus: A review of relevance and approach to treatment

Peláez-Jaramillo MJ et al. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0374-8

01-25-2018 | Heart failure | Review | Article

Effect of glucose-lowering therapies on heart failure

Nat Rev Cardiol 2018; Advance online publication. doi: 10.1038/nrcardio.2017.211

01-11-2018 | Cardiovascular outcomes | Review | Article

Direct cardiovascular impact of SGLT2 inhibitors: Mechanisms and effects

Kaplan A et al. Heart Fail Rev 2018; 23: 419–437. doi: 10.1007/s10741-017-9665-9

01-05-2018 | Cardiovascular outcomes | Review | Article

Pharmacological prevention of cardiovascular outcomes in diabetes mellitus: Established and emerging agents

Saxon DR, Rasouli N, Eckel RH. Drugs 2018; 78: 203–214. doi: 10.1007/s40265-017-0857-3

01-04-2018 | Medication adherence | Article

A class comparison of medication persistence in people with type 2 diabetes: A retrospective observational study

McGovern A et al. Diabetes Ther 2018; 9: 229–242. doi: 10.1007/s13300-017-0361-5

12-27-2017 | Ertugliflozin | Article

Ertugliflozin compared with glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin: The VERTIS SU randomized study

Hollander P et al. Diabetes Ther 2017; 9: 193–207. doi: 10.1007/s13300-017-0354-4

11-06-2017 | Omarigliptin | Article

A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin

Lee SH et al. BMC Endocr Disord 2017; 17: 70. doi: 10.1186/s12902-017-0219-x

11-02-2017 | Heart failure | Review | Article

Treating disease mechanisms in patients with heart failure and diabetes mellitus

Trang A, Aguilar D. Curr Heart Fail Rep 2017; 14: 445–453. doi: 10.1007/s11897-017-0371-7

10-23-2017 | Cardiovascular disorders | Review | Article

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: Recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG)

Schernthaner G et al. Cardiovasc Diabetol 2017; 16: 137. doi: 10.1186/s12933-017-0622-7

10-05-2017 | Hypoglycemia | Review | Article

A systematic approach for the prevention and reduction of hypoglycemia in hospitalized patients

Cruz P, Blackburn MC, Tobin GS. Curr Diab Rep 2017; 17: 117. doi: 10.1007/s11892-017-0934-8

09-08-2017 | Latent autoimmune diabetes of adulthood | Review | Article

Adult-onset autoimmune diabetes: Current knowledge and implications for management

Nat Rev Endocrinol 2017; 13: 674–686. doi: 10.1038/nrendo.2017.99

07-31-2017 | Diabetes prevention | Review | Article

Pharmaceutical interventions for diabetes prevention in patients at risk

Chatterjee S, Davies M, Khunti K. Am J Cardiovasc Drugs 2017; 1: 13–24. doi: 10.1007/s40256-017-0239-y

Next Previous